glipizide has been researched along with Weight Loss in 2 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The addition of sibutramine to oral hypoglycemic therapy resulted in significant weight loss and improvement in metabolic parameters in this patient group." | 5.09 | Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. ( Ertorer, EM; Gokcel, A; Guvener, N; Karakose, H; Tanaci, N; Tutuncu, NB, 2001) |
| "Weight loss was maintained throughout the study, which lasted 24 weeks." | 1.28 | Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes. ( Darga, LL; Holden, JH; Jen, KL; Kasim, SE; Khilnani, S; Lucas, CP; Patton, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gokcel, A | 1 |
| Karakose, H | 1 |
| Ertorer, EM | 1 |
| Tanaci, N | 1 |
| Tutuncu, NB | 1 |
| Guvener, N | 1 |
| Kasim, SE | 1 |
| Darga, LL | 1 |
| Holden, JH | 1 |
| Khilnani, S | 1 |
| Patton, S | 1 |
| Jen, KL | 1 |
| Lucas, CP | 1 |
1 trial available for glipizide and Weight Loss
| Article | Year |
|---|---|
Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control.
Topics: Appetite Depressants; Blood Glucose; Cholesterol; Cyclobutanes; Diabetes Mellitus; Double-Blind Meth | 2001 |
1 other study available for glipizide and Weight Loss
| Article | Year |
|---|---|
Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mel | 1991 |